Abelson, R., and A. Levi. 1985. Decision Making and Decision Theory. In The Handbook of Social Psychology, 3rd ed., vol. 1, ed. G. Linzey and E. Aronson, 231–310. New York: Random House.
Alonso-Magdalena, P., S. Morimoto, C. Ripoll, E. Fuentes, and A. Nadal. 2006. The Estrogenic Effect of Bisphenol-A Disrupts the Pancreatic ß-Cell Function in vivo and Induces Insulin Resistance. Environmental Health Perspectives 114: 106–12.
Als-Nielsen, B., W. Chen, C. Gluud, and L. Kjaergard. 2003. Association of Funding and Conclusions in Randomized Drug Trials. Journal of the American Medical Association 290: 921–28.
American Public Health Association (APHA). 2003. Supporting Legislation for Independent Post-marketing Phase IV Comparative Evaluation of Pharmaceuticals. Washington, D.C.: APHA. http://www.apha.org/advocacy/policy/policysearch/default.htm?id=1265 (accessed September 12, 2007).
Ames, B., and L. Gold. 1994. The Causes and Prevention of Cancer. Environmental Health Perspectives 105, suppl. 4: 865–74.
Ames, B., R. Magaw, and L. Gold. 1987. Ranking Possible Carcinogenic Hazards. Science 236: 271–80.
Anderson, E. 1995. Feminist Epistemology: An Interpretation and a Defense. Hypatia 10: 50–84.
———. 2004. Uses of Value Judgments in Science: A General Argument, with Lessons from a Case Study of Feminist Research on Divorce. Hypatia 19: 1–24.
Angell, M. 2004a. Time for a Drug Registry. Washington Post (August 13).
———. 2004b. The Truth about the Drug Companies: How They Deceive Us and What to Do about It. New York: Random House.
Anonymous. 1996. Conclusions and Recommendations of a Workshop on Multiple Chemical Sensitivities (MCS). Regulatory Toxicology and Pharmacology 24: S188–89.
Arnall, A., and D. Parr. 2005. Moving the Nanoscience and Technology (NST) Debate Forwards: Short-term Impacts, Long-term Uncertainty and the Social Constitution. Technology in Society 27: 23–38.